Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.

Belic J, Koch M, Ulz P, Auer M, Gerhalter T, Mohan S, Fischereder K, Petru E, Bauernhofer T, Geigl JB, Speicher MR, Heitzer E.

Adv Exp Med Biol. 2016;924:147-155.

PMID:
27753036
2.

Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.

Ulz P, Belic J, Graf R, Auer M, Lafer I, Fischereder K, Webersinke G, Pummer K, Augustin H, Pichler M, Hoefler G, Bauernhofer T, Geigl JB, Heitzer E, Speicher MR.

Nat Commun. 2016 Jun 22;7:12008. doi: 10.1038/ncomms12008.

3.

Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.

Belic J, Koch M, Ulz P, Auer M, Gerhalter T, Mohan S, Fischereder K, Petru E, Bauernhofer T, Geigl JB, Speicher MR, Heitzer E.

Clin Chem. 2015 Jun;61(6):838-49. doi: 10.1373/clinchem.2014.234286. Epub 2015 Apr 20.

4.

Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.

Seles M, Gutschi T, Mayrhofer K, Fischereder K, Ehrlich G, Gallé G, Gutschi S, Pachernegg O, Pummer K, Augustin H.

BJU Int. 2016 Apr;117(4):592-7. doi: 10.1111/bju.13108. Epub 2015 May 14.

5.

Cell phone usage and erectile function.

Al-Ali BM, Patzak J, Fischereder K, Pummer K, Shamloul R.

Cent European J Urol. 2013;66(1):75-7. doi: 10.5173/ceju.2013.01.art23. Epub 2013 Apr 26.

6.

Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study.

Ponholzer A, Trubel S, Schramek P, Wimpissinger F, Feichtinger H, Springer C, Wehrberger C, Fischereder K, Pummer K, Martini T, Mayr R, Pycha A, Madersbacher S.

World J Urol. 2014 Aug;32(4):911-6. doi: 10.1007/s00345-014-1252-2. Epub 2014 Feb 8.

PMID:
24510119
7.

Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?

El-Heliebi A, Kroneis T, Zöhrer E, Haybaeck J, Fischereder K, Kampel-Kettner K, Zigeuner R, Pock H, Riedl R, Stauber R, Geigl JB, Huppertz B, Sedlmayr P, Lackner C.

J Transl Med. 2013 Sep 17;11:214. doi: 10.1186/1479-5876-11-214.

8.

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.

Heitzer E, Ulz P, Belic J, Gutschi S, Quehenberger F, Fischereder K, Benezeder T, Auer M, Pischler C, Mannweiler S, Pichler M, Eisner F, Haeusler M, Riethdorf S, Pantel K, Samonigg H, Hoefler G, Augustin H, Geigl JB, Speicher MR.

Genome Med. 2013 Apr 5;5(4):30. doi: 10.1186/gm434. eCollection 2013.

9.

Early results of a European multicentre experience with a new self-anchoring adjustable transobturator system for treatment of stress urinary incontinence in men.

Hoda MR, Primus G, Fischereder K, Von Heyden B, Mohammed N, Schmid N, Moll V, Hamza A, Karsch JJ, Brössner C, Fornara P, Bauer W.

BJU Int. 2013 Feb;111(2):296-303. doi: 10.1111/j.1464-410X.2012.11482.x. Epub 2012 Nov 27.

10.

[Treatment of stress urinary incontinence after radical prostatectomy: adjustable transobturator male system - results of a multicenter prospective observational study].

Hoda MR, Primus G, Schumann A, Fischereder K, von Heyden B, Schmid N, Moll V, Hamza A, Karsch JJ, Steinbach F, Brössner C, Bauer W, Fornara P.

Urologe A. 2012 Nov;51(11):1576-83. doi: 10.1007/s00120-012-2950-2. German.

PMID:
22836942
11.

Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.

Zebisch A, Staber PB, Delavar A, Bodner C, Hiden K, Fischereder K, Janakiraman M, Linkesch W, Auner HW, Emberger W, Windpassinger C, Schimek MG, Hoefler G, Troppmair J, Sill H.

Cancer Res. 2006 Apr 1;66(7):3401-8.

Supplemental Content

Loading ...
Support Center